24.57  -0.23 (-0.93%)		04-24 16:00
Open: 24.57 High: 24.635 Volume: 1,182,271		Pre. Close: 24.8 Low: 24.43 Market Cap: 10,712(M)

Short term
Mid term
Targets	6-month :	29.69	1-year :	30.97
Resists	First :	25.42	Second :	26.52
Pivot price	24.23
Supports	First :	23.64	Second :	19.67
MAs	MA(5) :	24.31	MA(20) :	24.43
	MA(100) :	26.7	MA(250) :	27.4
MACD	MACD :	-0.6	Signal :	-0.7
%K %D	K(14,3) :	80.6	D(3) :	57.5
RSI	RSI(14): 44.9
52-week	High :	33.09	Low :	21.53

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ SNN ] has closed below upper band by 25.3%. Bollinger Bands are 35.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	24.66 - 24.79	24.79 - 24.9
Low:	24.12 - 24.27	24.27 - 24.39
Close:	24.33 - 24.58	24.58 - 24.79

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

Wed, 24 Apr 2024
Anna Deavere Smith talks life, work ahead of A.W. Mellon lectures - The Washington Post - The Washington Post

Wed, 24 Apr 2024
Manhunt underway for 'armed and dangerous' suspect wanted in ongoing Gadsden County death investigation - WCTV

Wed, 24 Apr 2024
Alex Smith's HS teammate Reggie Bush gets Heisman back, football world rejoices - Chiefs Wire

Wed, 24 Apr 2024
Jack Smith 'Hypothetical' Could Turn Trump Immunity Claim Against SCOTUS - Newsweek

Tue, 23 Apr 2024
Fort Smith considers new rules for new construction projects near the airport - 4029tv

Tue, 23 Apr 2024
Danielle Smith defends appointment of task force led by doctor skeptical of COVID measures - The Globe and Mail

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Outperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Outperform

Exchange: NYSE
Sector: Healthcare
Industry: Medical - Devices
Shares Out	437 (M)
Shares Float	863 (M)
Held by Insiders	0 (%)
Held by Institutions	7.5 (%)
Shares Short	1,980 (K)
Shares Short P.Month	2,220 (K)

EPS	0.6
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	5.98
Profit Margin	4.7 %
Operating Margin	14.4 %
Return on Assets (ttm)	4.2 %
Return on Equity (ttm)	5 %
Qtrly Rev. Growth	7.5 %
Gross Profit (p.s.)	0
Sales Per Share	12.69
EBITDA (p.s.)	2.56
Qtrly Earnings Growth	98.3 %
Operating Cash Flow	608 (M)
Levered Free Cash Flow	212 (M)

PE Ratio	40.94
PEG Ratio	0
Price to Book value	4.1
Price to Sales	1.93
Price to Cash Flow	17.66

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.